ArticleFrontiers in oncology2023

CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy.

Hongtuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.